{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:38:56Z","timestamp":1777531136323,"version":"3.51.4"},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.transproceed.2004.01.039","type":"journal-article","created":{"date-parts":[[2004,3,19]],"date-time":"2004-03-19T16:07:14Z","timestamp":1079712434000},"page":"S323-S330","source":"Crossref","is-referenced-by-count":20,"special_numbering":"S","title":["Cardiac transplant experience with cyclosporine"],"prefix":"10.1016","volume":"36","author":[{"given":"J.K","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A","family":"Kobashigawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2004.01.039_BIB1","first-page":"307","article-title":"Results of 54 cardiac transplants","volume":"74","author":"Caves","year":"1973","journal-title":"Surgery"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB2","first-page":"1017","article-title":"Effects of the new anti-lymphocytic peptide cyclosporin A in animals","volume":"32","author":"Borel","year":"1977","journal-title":"Immunology"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB3","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00000658-198209000-00011","article-title":"Cardiac transplantation with cyclosporin A and prednisone","volume":"196","author":"Griffith","year":"1982","journal-title":"Ann Surg"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB4","first-page":"2546","article-title":"Cyclosporine in cardiac transplantation","volume":"15","author":"Oyer","year":"1983","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB5","first-page":"2567","article-title":"Cardiac and cardiopulmonary transplantation using cyclosporine for immunosuppression","volume":"15","author":"Cooley","year":"1983","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB6","first-page":"2559","article-title":"Cyclosporine for cardiac transplantation","volume":"15","author":"Wallwork","year":"1983","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB7","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0041-1345(98)00469-2","article-title":"Cyclosporine heart transplantation","volume":"30","author":"Cheung","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0041-1345(96)00327-2","article-title":"Multicenter evaluation of immunosuppressive regimens in heart transplantation. The Collaborative Transplant Study","volume":"29","author":"Opelz","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB9","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0022-5223(19)36981-8","article-title":"Eight-year results of cyclosporine-treated patients with cardiac transplants","volume":"99","author":"Grattan","year":"1990","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB10","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1073\/pnas.81.16.5214","article-title":"Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription","volume":"81","author":"Kronke","year":"1984","journal-title":"Proc Nati Acad Sci U S A"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB11","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.4049\/jimmunol.136.4.1315","article-title":"Immunosuppressive effects of cyclosporin A on cloned T cells","volume":"136","author":"Herold","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB12","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1084\/jem.168.5.1649","article-title":"In situ hybridization for interleukin 2 and interleukin 2 receptor mRNA in T cells activated in the presence or absence of cyclosporin A","volume":"168","author":"Granelli-Piperno","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/382370a0","article-title":"Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4","volume":"382","author":"Shibasaki","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1146\/annurev.immunol.15.1.707","article-title":"Transcription factors of the NFAT family","volume":"15","author":"Rao","year":"1997","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB15","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1002\/j.1460-2075.1994.tb06757.x","article-title":"AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes","volume":"13","author":"Rincon","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/cimm.1994.1255","article-title":"FK506 and cyclosporin A each inhibit antigen-specific signaling in the T cell line 171 in the absence of a calcium signal","volume":"158","author":"Metcalfe","year":"1994","journal-title":"Cell Immunol"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB17","doi-asserted-by":"crossref","first-page":"12378","DOI":"10.1074\/jbc.273.20.12378","article-title":"T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK\/JNK signaling pathways sensitive to cyclosporin A","volume":"273","author":"Matsuda","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB18","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/S0041-1345(98)00472-2","article-title":"Comparative bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1 year","volume":"30","author":"Cooney","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00007890-200101150-00012","article-title":"Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients","volume":"71","author":"Eisen","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB20","first-page":"469","article-title":"Comparison of Neoral and Sandimmune cyclosporine for induction of immunosuppression after heart transplantation","volume":"13","author":"Carrier","year":"1997","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB21","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/S0041-1345(98)00476-X","article-title":"Neoral versus Sandimmun","volume":"30","author":"Maccherini","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB22","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/S0041-1345(98)00477-1","article-title":"Long-term safety and efficacy of Neoral in heart transplantation","volume":"30","author":"Yonan","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/clinchem\/48.1.69","article-title":"Rapid liquid chromatography-tandem mass spectrometry method for routine analysis of cyclosporin A over an extended concentration range","volume":"48","author":"Keevil","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5858\/2003-127-19-LOSOC","article-title":"Lack of specificity of cyclosporine immunoassays. Results of a College of American Pathologists Study","volume":"127","author":"Soldin","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0149-2918(02)85038-X","article-title":"Therapeutic drug monitoring of immunosuppressant drugs in clinical practice","volume":"24","author":"Kahan","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB26","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1097\/00007890-199612270-00009","article-title":"A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study Group","volume":"62","author":"Keown","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB27","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1097\/00007890-199706270-00011","article-title":"Kidney function after 1:1 conversion to the cyclosporine microemulsion formulation in children with liver allografts","volume":"63","author":"Laine","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB28","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/00007890-199911150-00023","article-title":"The temporal profile of calcineurin inhibition by cyclosporine in vivo","volume":"8","author":"Halloran","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB29","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/clinchem\/45.9.1477","article-title":"Inhibition of stimulated interleukin-2 production in whole blood","volume":"45","author":"Stein","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00007890-199907150-00011","article-title":"Neoral monitoring by simplified sparse sampling area under the concentration-time curve","volume":"68","author":"Mahalati","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB31","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1097\/00007890-199912270-00003","article-title":"Clinical benefit of neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients","volume":"68","author":"Cantarovich","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00001573-199707000-00005","article-title":"Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine","volume":"12","author":"Ventura","year":"1997","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00007890-199702150-00001","article-title":"Hyperlipidemia in solid organ transplantation","volume":"63","author":"Kobashigawa","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB34","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/clinids\/11.5.677","article-title":"Infection and cyclosporine","volume":"11","author":"Kim","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB35","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/17401","article-title":"Cyclosporine induces cancer progression by a cell-autonomous mechanism","volume":"397","author":"Hojo","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB36","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(79)92440-1","article-title":"Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs","volume":"2","author":"Calne","year":"1979","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.transproceed.2004.01.039_BIB37","doi-asserted-by":"crossref","first-page":"S353","DOI":"10.1111\/j.1432-2277.1994.tb01390.x","article-title":"Non-Hodgkin's lymphoma after kidney or heart transplantation","volume":"7","author":"Opelz","year":"1994","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB38","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(84)90994-2","article-title":"Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy","volume":"1","author":"Starzl","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB39","doi-asserted-by":"crossref","unstructured":"Swinnen LJ: Post-transplant lymphoproliferative disorders: implications for acquired immunodeficiency syndrome-associated malignancies. J Natl Cancer Inst Monogr 28:38, 2001","DOI":"10.1093\/oxfordjournals.jncimonographs.a024255"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB40","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0140-6736(05)80084-4","article-title":"Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients","volume":"342","author":"Opelz","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB41","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0041-1345(98)01987-3","article-title":"Posttransplant malignancies","volume":"31","author":"Penn","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB42","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/00007890-198112000-00007","article-title":"Cyclosporin A hepatotoxicity in 66 renal allograft recipients","volume":"32","author":"Klintmalm","year":"1981","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB43","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1525-1594.1988.tb02762.x","article-title":"Prevalence and causes of long-lasting hepatic dysfunction after heart transplantation","volume":"12","author":"Cadranel","year":"1988","journal-title":"Artif Organs"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB44","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/ki.1988.38","article-title":"The long-term course of cyclosporine-associated chronic nephropathy","volume":"33","author":"Myers","year":"1988","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB45","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S1053-2498(01)00411-9","article-title":"The incidence of end-stage renal failure in 17 years of heart transplantation","volume":"21","author":"Satchithananda","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB46","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0041-1345(98)00177-8","article-title":"Survival of heart transplant recipients with cyclosporine-induced renal insufficiency","volume":"30","author":"van Gelder","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB47","first-page":"972","article-title":"Five years' follow-up of renal glomerular and tubular functions in heart transplant recipients","volume":"15","author":"Hartmann","year":"1996","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB48","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1097\/00007890-200004270-00012","article-title":"Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine","volume":"69","author":"Aleksic","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB49","first-page":"155","article-title":"Renal dysfunction in animal models of cyclosporine toxicity","volume":"17","author":"Paller","year":"1985","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB50","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1093\/ndt\/12.10.2054","article-title":"Cyclosporin nephrotoxicity following cardiac transplantation","volume":"12","author":"Woolfson","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB51","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0735-1097(02)02822-X","article-title":"High-dose angiotensin-converting enzyme inhibition restores body fluid homeostasis in heart-transplant recipients","volume":"41","author":"Braith","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB52","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/oxfordjournals.ndt.a027264","article-title":"Effects of the prostacyclin analogue iloprost on cyclosporin-induced renal hypoperfusion in stable renal transplant recipients","volume":"11","author":"Hansen","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB53","first-page":"535","article-title":"Cyclosporin exerts a direct fibrogenic effect on human tubulointerstitial cells","volume":"289","author":"Johnson","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB54","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00007890-199808270-00016","article-title":"A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators","volume":"66","author":"Kobashigawa","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB55","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1053-2498(98)00060-6","article-title":"A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation","volume":"18","author":"Taylor","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB56","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1053-2498(00)00567-2","article-title":"European multicenter tacrolimus heart pilot study","volume":"20","author":"Reichart","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB57","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0003-4975(92)91371-F","article-title":"Clinical trial of FK 506 immunosuppression in adult cardiac transplantation","volume":"54","author":"Armitage","year":"1992","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB58","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00007890-199801150-00021","article-title":"Tacrolimus as a rescue immunosuppressant after heart and lung transplantation. The U.S. Multicenter FK506 Study Group","volume":"65","author":"Mentzer","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB59","first-page":"795","article-title":"Tacrolimus","volume":"16","author":"Meiser","year":"1997","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB60","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1053-2498(00)00222-9","article-title":"Suggested guidelines for the use of tacrolimus in cardiac transplant recipients","volume":"20","author":"Taylor","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB61","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1016\/S0041-1345(03)00229-X","article-title":"Sirolimus therapy in cardiac transplantation","volume":"35","author":"Radovancevic","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB62","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.CIR.0000070421.38604.2B","article-title":"Use of rapamycin slows progression of cardiac transplantation vasculopathy","volume":"108","author":"Mancini","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB63","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2004.01.039_BIB64","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/01.TP.0000074360.62032.39","article-title":"Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study","volume":"76","author":"Oberbauer","year":"2003","journal-title":"Transplantation"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134504000909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134504000909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T04:30:41Z","timestamp":1682656241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134504000909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0041134504000909"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2004.01.039","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}